Biogen’s Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business DailyBiogen’s turnaround is still a “work in progress,” an analyst said Tuesday as Biogen stock slumped on light fourth-quarter profit.
The post Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue appeared first on Investor&…